CRMD
NASD CorMedix Inc.$7.39 ↑ +0.00 (+0.00%) Trading Up from the previous close of $7.39, $0.16 below the day’s high of $7.55
- YTD change
- -36.46%
- vs 20-day SMA
- -2.80%
- vs 200-day SMA
- -6.08%
Price ranges
Price & Performance
+0.07 (+0.96%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 60.7% away from all-time highs of $18.80
- CRMD is down 36% since the beginning of the year
- CRMD is down 30% over the past 12 months
- CRMD is down 6% over the past 1 month
- 20% of all CRMD investors are betting against CRMD
CRMD reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -30.2%.
- Previous minute
- +$0.00
- Last hour
- -$0.11
- Last 5 days
- +1.79%
- vs 8-day SMA
- +0.90%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.